Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Cuprizone-induced graded oligodendrocyte vulnerability is regulated by the transcription factor DNA damage-inducible transcript 3.

Glia | 2019

Oligodendrocytes are integral to efficient neuronal signaling. Loss of myelinating oligodendrocytes is a central feature of many neurological diseases, including multiple sclerosis (MS). The results of neuropathological studies suggest that oligodendrocytes react with differing sensitivity to toxic insults, with some cells dying early during lesion development and some cells being resistant for weeks. This proposed graded vulnerability has never been demonstrated but provides an attractive window for therapeutic interventions. Furthermore, the biochemical pathways associated with graded oligodendrocyte vulnerability have not been well explored. We used immunohistochemistry and serial block-face scanning electron microscopy (3D-SEM) to show that cuprizone-induced metabolic stress results in an "out of phase" degeneration of oligodendrocytes. Although expression induction of stress response transcription factors in oligodendrocytes occurs within days, subsequent oligodendrocyte apoptosis continues for weeks. In line with the idea of an out of phase degeneration of oligodendrocytes, detailed ultrastructural reconstructions of the axon-myelin unit demonstrate demyelination of single internodes. In parallel, genome wide array analyses revealed an active unfolded protein response early after initiation of the cuprizone intoxication. In addition to the cytoprotective pathways, the pro-apoptotic transcription factor DNA damage-inducible transcript 3 (DDIT3) was induced early in oligodendrocytes. In advanced lesions, DDIT3 was as well expressed by activated astrocytes. Toxin-induced oligodendrocyte apoptosis, demyelination, microgliosis, astrocytosis, and acute axonal damage were less intense in the Ddit3-null mutants. This study identifies DDIT3 as an important regulator of graded oligodendrocyte vulnerability in a MS animal model. Interference with this stress cascade might offer a promising therapeutic approach for demyelinating disorders.

Pubmed ID: 30511355 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Iba1 antibody (antibody)

RRID:AB_10972670

This polyclonal targets Iba1 antibody

View all literature mentions

ANTI-OLIG-2 (antibody)

RRID:AB_570666

This polyclonal targets Oligodendrocute transcription factor 2

View all literature mentions

ATF-3 (C-19) (antibody)

RRID:AB_2258513

This polyclonal targets ATF-3 (C-19)

View all literature mentions

ubiquitin (antibody)

RRID:AB_2315524

This unknown targets

View all literature mentions

GADD153 antibody [9C8] (antibody)

RRID:AB_298023

This monoclonal targets GADD153

View all literature mentions

CHOP (L63F7) Mouse mAb (antibody)

RRID:AB_2089254

This monoclonal targets CHOP

View all literature mentions

GADD 153 (F-168) (antibody)

RRID:AB_631365

This polyclonal targets DDIT3

View all literature mentions

Iba1 antibody (antibody)

RRID:AB_10972670

This polyclonal targets Iba1 antibody

View all literature mentions

ANTI-OLIG-2 (antibody)

RRID:AB_570666

This polyclonal targets Oligodendrocute transcription factor 2

View all literature mentions

GADD153 antibody [9C8] (antibody)

RRID:AB_298023

This monoclonal targets GADD153

View all literature mentions

GADD 153 (F-168) (antibody)

RRID:AB_631365

This polyclonal targets DDIT3

View all literature mentions

ATF-3 (C-19) (antibody)

RRID:AB_2258513

This polyclonal targets ATF-3 (C-19)

View all literature mentions

CHOP (L63F7) Mouse mAb (antibody)

RRID:AB_2089254

This monoclonal targets CHOP

View all literature mentions

ubiquitin (antibody)

RRID:AB_2315524

This unknown targets

View all literature mentions